| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/24/2002 | CN1360592A Streptogramin derivs., production thereof and composition contg. same |
| 07/24/2002 | CN1360507A Conjugates and method for production thereof, and their use for transporting molecules via biological membranes |
| 07/24/2002 | CN1360506A Growth hormone formulations |
| 07/24/2002 | CN1360505A Pseudomycin antifungal compositions and method for their use |
| 07/24/2002 | CN1360496A Dry powder compositions |
| 07/24/2002 | CN1360052A Polypeptide-triose-phosphate isomerase 17.60 and polynucleotide for coding it |
| 07/24/2002 | CN1360051A Polypeptide-human lyase-fimily protein 26.29 using fumarate as substrate and polynucleotide for coding it |
| 07/24/2002 | CN1360050A Polypeptide-human fumarate lyase 10.89 and polynucleotide for coding it |
| 07/24/2002 | CN1360049A Polypeptide-human L-asparaginase 24.53 and polynucleotide for coding it |
| 07/24/2002 | CN1360048A Polypeptide-AIDS associated protein 9.9 and polynucleotide for coding it |
| 07/24/2002 | CN1360047A Polypeptide-human protein 13.42 containing signal peptidase characteristic sequence fragment and polynucleotide for coding it |
| 07/24/2002 | CN1360046A Polypeptide-signal peptidase 11.77 and polynucleotide for coding it |
| 07/24/2002 | CN1360045A Polypeptide-protein phosphatase 2C-27.83 and polynucleotide for coding it |
| 07/24/2002 | CN1360044A Polypeptide-human phosphatidic acid phosphatase 2-9.13 and polynucleotide for coding it |
| 07/24/2002 | CN1360043A Polypeptide-human RNA uncoiling enzyme 12.32 and polynucleotide for coding it |
| 07/24/2002 | CN1360042A Polypeptide-human Ser/Thr protein kinase 55.66 and polynucleotide for coding it |
| 07/24/2002 | CN1360041A Polypeptide-tyrosine-specific protein phosphatase 24.97 and polynucleotide for coding it |
| 07/24/2002 | CN1360040A Polypeptide-protein phosphatase 1 regulatory subunit 10-12.54 and polynucleotide for coding it |
| 07/24/2002 | CN1360039A Polypeptide-tyrosine protein kinase 10.56 and polynucleotide for coding it |
| 07/24/2002 | CN1360038A Polypeptide-human protein kinase 11.66 and polynucleotide for coding it |
| 07/24/2002 | CN1360037A Polypeptide-human signal transducer kinase 9.68 and polynucleotide for coding it |
| 07/24/2002 | CN1360036A Polypeptide-human sulfotransferase 77.55 and polynucleotide for coding it |
| 07/24/2002 | CN1360035A Polypeptide-human succinic dehydrogenase 11.66 and polynucleotide for coding it |
| 07/24/2002 | CN1360034A Polypeptide-human dehydrogenase 10.01 and polynucleotide for coding it |
| 07/24/2002 | CN1360033A Polypeptide-human dioxygenase 12.43 and polynucleotide for coding it |
| 07/24/2002 | CN1360032A Polypeptide-human lysyloxidase 15.29 and polynucleotide for coding it |
| 07/24/2002 | CN1360031A Polypeptide-human NADH ubiquinone oxide-reductase 15.07 and polynucleotide for coding it |
| 07/24/2002 | CN1360030A Polypeptide-human pterin molybdenum oxido-reductase 12.98 and polynucleotide for coding it |
| 07/24/2002 | CN1360027A Polypeptide-human sailor transposase 9.35 and polynucleotide for coding it |
| 07/24/2002 | CN1360022A Recombinant human epidermal growth factor and its preparing process and medicinal composition |
| 07/24/2002 | CN1359730A Animal nipple degerming agent and method for improving germ environment |
| 07/24/2002 | CN1359729A Application of serum beta 2-glucoprotein I as active component of thrombolytics and its functional peptide fragment |
| 07/24/2002 | CN1359728A Medicine for treating wart |
| 07/24/2002 | CN1359727A Medicinal composition containing hepatitis B-resistant transfer factor and Lamivudine |
| 07/24/2002 | CN1359693A Process for preparing dried soybean polypeptide powder with hypolipemic action |
| 07/24/2002 | CN1359630A Process for preparing protein powder by enzymolyzing whole egg with papainase and use of said protein powder |
| 07/24/2002 | CN1087943C Stable extract of hyperricum perforatum, process for preparing same and pharmaceutical compositions |
| 07/24/2002 | CN1087940C Brain protein hydrolysate |
| 07/23/2002 | US6423869 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423835 Medical diagnosis of infections; vaccines; genetic engineering and expression |
| 07/23/2002 | US6423827 Diagnosis of psychological disorders |
| 07/23/2002 | US6423825 Therapeutic derivative compounds derived from domain II of bactericidal/permeability-increasing protein |
| 07/23/2002 | US6423823 Fungicidal, miticidal, and nematocidal omphalotin derivative |
| 07/23/2002 | US6423822 Treating genetic and cell cycle disorders of mitosis; antitumor agents; gene expression |
| 07/23/2002 | US6423744 Administering an amount of a leukotriene b4 (ltb4) antagonist, preferably a ltb4 receptor antagonistic, to a patient exhibiting adverse drug effect due to exogenous interleukin-2, to decrease the adverse effects |
| 07/23/2002 | US6423723 Oral bioavailability |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423699 Contraceptives |
| 07/23/2002 | US6423693 Growth hormone releasing hormone expression system and methods of use, including use in animals |
| 07/23/2002 | US6423692 Transducing a target cell with a nucleic acid sequence encoding a dck protein (deoxycytidine kinase) having phosphorylation activity operably linked to a promoter |
| 07/23/2002 | US6423689 Peptidyl calcium channel blockers |
| 07/23/2002 | US6423688 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/23/2002 | US6423687 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/23/2002 | US6423686 LHRH antagonist peptides |
| 07/23/2002 | US6423685 Method for increasing the serum half-life of a biologically active molecule |
| 07/23/2002 | US6423683 Microdose therapy |
| 07/23/2002 | US6423682 Sprouty related growth factor antagonist (FGFAn-Hy) materials and methods |
| 07/23/2002 | US6423681 Method of inducing formation of kidney epithelia from mesenchymal precursors |
| 07/23/2002 | US6423680 Inhibitor of platelet activating factor |
| 07/23/2002 | US6423546 Monoclonal antibodies for assaying lipid transfer proteins |
| 07/23/2002 | US6423543 Antisense modulation of hepsin expression |
| 07/23/2002 | US6423539 Enhancing immunology response |
| 07/23/2002 | US6423527 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/23/2002 | US6423521 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/23/2002 | US6423519 Contacting fungal cell with compound which inhibits prenyltransferase activity of cell, including permease tag which facilitates permease-mediated transport of compound into cell, inhibiting growth thereof |
| 07/23/2002 | US6423513 Polynucleotide encoding proprotein comprising cell recognition domain binding to exterior surface of targeted cell, domain effecting translocation to cell cytosol upon proteolytic cleavage, cytotoxicity domain, endoplasmic reticulum retention |
| 07/23/2002 | US6423512 Fusion polypeptides |
| 07/23/2002 | US6423511 Humanized antibodies |
| 07/23/2002 | US6423507 Detecting enzyme inhibitors; obtain protease, incubate with modulator, monitor adjustment in protease activity |
| 07/23/2002 | US6423501 Calcium-independent negative regulation by CD81 of receptor signaling |
| 07/23/2002 | US6423500 Mammalian receptors for interleukin-10 |
| 07/23/2002 | US6423498 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders |
| 07/23/2002 | US6423496 Nucleotide sequences for use in the detection, diagnosis and monitoring of mammary gland tumors |
| 07/23/2002 | US6423493 Detecting preferential nucleotide sequences in sample; obtain nucleotide sequences library, amplify library, incubate with probe, recover nucleotide sequences |
| 07/23/2002 | US6423347 Antiarthritic agents in liquid form |
| 07/23/2002 | US6423344 Dispersion of dry powders, atomizing, drying and accumulation of particles |
| 07/23/2002 | US6423333 Sealing or filling tissue defects using polyfunctional crosslinking agents and protein polymers |
| 07/23/2002 | US6423327 Treating wrinkles of skin with adenosine |
| 07/23/2002 | US6423321 Administering therapeutically effective dosage level to human of etanercept for reducing inflammation or for modulating immune response affecting auditory apparatus |
| 07/23/2002 | US6423319 Methods for treating muscle injuries |
| 07/23/2002 | US6423316 Anticoagulant fusion protein anchored to cell membrane |
| 07/23/2002 | US6423315 Antiarthritic agents |
| 07/23/2002 | US6423313 Inhibition of tumor growth by blockade of the protein C system |
| 07/23/2002 | US6423312 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 07/23/2002 | US6423311 Mammals grafting cells with radiation |
| 07/23/2002 | US6423308 Treatment of Kaposi's sarcoma with IL-12 |
| 07/23/2002 | US6423299 Aerosols for bacterial infections |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2215317C Reduction of adhesions using controlled delivery of active oxygen inhibitors |
| 07/23/2002 | CA2204911C Glial derived neurotrophic factor as a neuroprotective agent |
| 07/23/2002 | CA2168440C Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer |
| 07/23/2002 | CA2124941C Dna fragment encoding tumor cell growth inhibitors |
| 07/23/2002 | CA2102509C Immunostimulatory agent |
| 07/23/2002 | CA2101556C Growth factor containing matrix for the treatment of cartilage lesions |
| 07/23/2002 | CA2091769C Framework mutated antibodies and their preparation |
| 07/23/2002 | CA2087450C Stable and bioactive modified somatotropins |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2060560C Method for insuring adequate intracellular glutathione in tissue |
| 07/23/2002 | CA2058597C Wound healing compositions containing fibroblast growth factor and ascorbic acid |